Case Study: MOE Therapeutics improves data integrity and compliance with CRIO eSource

Cras favor crio over paper By 3:1 margins on key Dimensions

The customer, MOE Therapeutics, a small device manufacturer, was conducting a Phase 3 clinical trial. A CRA from the sponsor noticed that one site using the CRIO eSource system outperformed its paper-based counterparts, highlighting a challenge in achieving optimal data quality and monitoring efficiency with traditional methods.

The vendor, CRIO, provided its eSource system, which enabled remote monitoring, built-in quality safeguards, and real-time data access. This solution resulted in substantially better data quality and significant time and cost savings for the CRA. A subsequent survey of CRA users confirmed these benefits, with CRIO being favored over paper by a 3:1 margin on key dimensions like promoting data integrity and compliance.